摘要
目的探究成人支原体肺炎治疗中采用莫西沙星进行治疗的临床治疗效果。方法选择广州市南沙区第二人民医院在2013年5月至2015年5月期间收治的成人支原体肺炎患者220例,采用随机数字法将其分为对照组和实验组,每110例为1组,对照组采用阿奇霉素进行治疗,而实验组则采用莫西沙星进行治疗,将两组患者的治疗效果进行对比分析。结果与对照组相比,实验组患者的治疗总有效率明显较高,而不良反应发生率明显较低,两项差异对比均P<0.05,存在统计学意义。结论在成人支原体肺炎治疗中采用莫西沙星有显著的效果,值得在临床上应用推广。
Objective To explore the treatment of mycoplasma pneumonia in adults using clinical effect of moxifloxacin for treatment. Methods Adult patients in our hospital mycoplasma pneumonia from May2013 to May 2015 period were treated 220 cases were randomly divided into a control method and experimental groups,each of 110 cases as a group and the control group using azithromycin treatment,while the experimental group moxifloxacin is used for treatment,the therapeutic effect of two groups of patients were analyzed. Results Compared with the control group, the experimental group were significantly higher total efficiency of treatment,and a significantly lower incidence of adverse reactions,both contrast differences were P 〈0. 05,statistically significant. Conclusion Moxifloxacin has a significant effect in adult mycoplasma pneumonia treatment,it is worth to promote the application in clinical practice.
出处
《广东微量元素科学》
CAS
2016年第8期35-37,共3页
Trace Elements Science
关键词
莫西沙星
支原体肺炎
临床效果
moxifloxacin
mycoplasma pneumoniae
clinical effect
